WBR0348: Difference between revisions

Jump to navigation Jump to search
No edit summary
m (refreshing WBR questions)
 
(2 intermediate revisions by one other user not shown)
Line 1: Line 1:
{{WBRQuestion
{{WBRQuestion
|QuestionAuthor={{Rim}} {{Alison}}
|QuestionAuthor= {{SSK}} (Reviewed by Serge Korjian)
|ExamType=USMLE Step 1
|ExamType=USMLE Step 1
|MainCategory=Pharmacology
|MainCategory=Pharmacology
Line 8: Line 8:
|MainCategory=Pharmacology
|MainCategory=Pharmacology
|SubCategory=Neurology
|SubCategory=Neurology
|MainCategory=Pharmacology
|MainCategory=Pharmacology
|MainCategory=Pharmacology
|MainCategory=Pharmacology
|MainCategory=Pharmacology
Line 20: Line 21:
|MainCategory=Pharmacology
|MainCategory=Pharmacology
|SubCategory=Neurology
|SubCategory=Neurology
|Prompt=An anesthesiology resident, prepping a patient for open reduction and internal fixation of a radial fracture, attempts his first axillary brachial plexus block. He begins by carefully palpating the axillary artery, keeping it fixed between two fingers, and then inserts a needle slightly above the artery. He then advances the needle and injects 250 mg of bupivacaine. While withdrawing the needle, the resident notices significant bright red blood flowing out of  the needle tubing and realizes that he might have accidentally injected the anesthetic intravascularly. Which of the following signs should be expected to occur in this patient?
|Prompt=An anesthesiology resident is prepping a patient for open reduction and internal fixation of a radial fracture. He is attempting his first axillary brachial plexus block. He begins by carefully palpating the axillary artery, trying to keep it fixed between two fingers and then inserts a needle slightly above the artery. He then advances the needle and injects 250 mg of bupivacaine. While withdrawing the needle, the resident notices significant bright red blood flowing out of  the needle tubing and realizes that he might have accidentally injected the anesthetic intravascularly. Which of the following signs should be expected to occur in this patient?
|Explanation=[[Bupivacaine]], a local anaesthetic used in nerve blocks, epidurals, and intrathecal anesthesia, acts by binding to neuronal sodium channels and blocking sodium influx, leadimg to a block of depolarization. With proper handling [[bupivacaine]] is relatively safe, but when accidentally injected into the bloodstream, it is associated with significant cardiotoxicity. By the same mechanism, [[bupivacaine]] blocks sodium channels in the cardiac muscle fibers often leading to [[bradicardia]], [[hypotension]], and eventual cardiac arrest. Several reports have demonstrated serious cardiotoxicity with difficult resuscitation, especially in pregnant women. Several meausres have been introduced to decrease toxicity from anesthetic drugs, including improved teaching and monitoring of students, as well as technical steps such as aspiration, incremental injection, dose control, and the use of test doses.
|Explanation=Bupivacaine is a local anaesthetic used in nerve blocks, epidurals, and intrathecal anesthesia. It acts by binding to neuronal sodium channels and blocking sodium influx. This leads to a block of depolarization. Although bupivacaine is relatively safe with proper handling, when injected accidentally into the bloodstream, it is associated with significant cardiotoxicity. By the same mechanism, it blocks sodium channels in the cardiac muscle fibers often leading to significant bradycardia, hypotension and eventual cardiac arrest. Several reports have shown serious cardiotoxicity with difficult resuscitation especially in pregnant women. Several measures have been introduced to decrease toxicity from anesthetic drugs including better teaching and monitoring of students as well as technical steps such as aspiration, incremental injection, dose control, the use of test doses, and ultrasound guidance.
 
 
|EducationalObjectives= [[Bupivacaine]] can cause significant cardiotoxicity by blocking cardiac sodium channels.
 
 
|References= Mulroy MF. Systemic toxicity and cardiotoxicity from local anesthetics: incidence and preventive measures. Reg Anesth Pain Med. 2002;27(6):556-61.
|AnswerA=Hypothermia
|AnswerA=Hypothermia
|AnswerAExp=[[Volatile anesthetics]] can cause hypothermia due to their inhibition of [[tonic thermoregulatory vasoconstriction]].
|AnswerAExp=Volatile anesthetics can sometimes cause hypothermia due to their inhibition of tonic thermoregulatory vasoconstriction.
|AnswerB=Hyperthermia
|AnswerB=Hyperthermia
|AnswerBExp=Hyperthemia, specifically malignant hyperthermia, can result from the adminstration of succinycholine, pancuronium, and other muscle relaxants, as well as inhaled anesthetics. Malignant hyperthermia is almost never assoicated with bupivacaine.
|AnswerBExp=Hyperthermia, specifically malignant hyperthermia can be seen with succinycholine, pancuronium, and other muscle relaxants, as well as inhaled anesthetics. Malignant hyperthermia is almost never associated with bupivacaine.
|AnswerC=Hypertension and tachycardia
|AnswerC=Hypertension and tachycardia
|AnswerCExp=Bupivacaine can cause cardiotoxicity and arrest, with initial signs being [[hypotension]] and [[bradycardia]], rather than hypertension and [[tachycardia]].
|AnswerCExp=Bupivacaine causes cardiotoxicity and arrest, with initial signs being hypotension and bradycardia rather than hypertension and tachycardia.
|AnswerD=Hypotension and bradycardia
|AnswerD=Hypotension and bradycardia
|AnswerDExp=[[Hypotension]] and [[bradycardia]] are the earliest signs of [[bupivacaine cardiotoxicity]].
|AnswerDExp=Hypotension and bradycardia are the earliest signs of bupivacaine cardiotoxicity.
|AnswerE=Respiratory arrest
|AnswerE=Respiratory arrest
|AnswerEExp=Respiratory arrest is not a complication of bupivacaine injection.
|AnswerEExp=Respiratory arrest is not a complication of bupivacaine injection.
|EducationalObjectives=Bupivacaine can cause significant cardiotoxicity if injected intravascularly by blocking cardiac sodium channels.
|References=Mulroy MF. Systemic toxicity and cardiotoxicity from local anesthetics: incidence and preventive measures. Reg Anesth Pain Med. 2002;27(6):556-61.
|RightAnswer=D
|RightAnswer=D
|WBRKeyword=Bupivacaine, cardiotoxicity, local anesthetics, cardiovascular, cardiology, hypotension, bradycardia
|WBRKeyword=Bupivacaine, Cardiotoxicity, Local anesthetics, Anesthesia,  
|Approved=Yes
|Approved=Yes
}}
}}

Latest revision as of 00:15, 28 October 2020

 
Author [[PageAuthor::Serge Korjian M.D. (Reviewed by Serge Korjian)]]
Exam Type ExamType::USMLE Step 1
Main Category MainCategory::Pharmacology
Sub Category SubCategory::Neurology
Prompt [[Prompt::An anesthesiology resident is prepping a patient for open reduction and internal fixation of a radial fracture. He is attempting his first axillary brachial plexus block. He begins by carefully palpating the axillary artery, trying to keep it fixed between two fingers and then inserts a needle slightly above the artery. He then advances the needle and injects 250 mg of bupivacaine. While withdrawing the needle, the resident notices significant bright red blood flowing out of the needle tubing and realizes that he might have accidentally injected the anesthetic intravascularly. Which of the following signs should be expected to occur in this patient?]]
Answer A AnswerA::Hypothermia
Answer A Explanation AnswerAExp::Volatile anesthetics can sometimes cause hypothermia due to their inhibition of tonic thermoregulatory vasoconstriction.
Answer B AnswerB::Hyperthermia
Answer B Explanation AnswerBExp::Hyperthermia, specifically malignant hyperthermia can be seen with succinycholine, pancuronium, and other muscle relaxants, as well as inhaled anesthetics. Malignant hyperthermia is almost never associated with bupivacaine.
Answer C AnswerC::Hypertension and tachycardia
Answer C Explanation AnswerCExp::Bupivacaine causes cardiotoxicity and arrest, with initial signs being hypotension and bradycardia rather than hypertension and tachycardia.
Answer D AnswerD::Hypotension and bradycardia
Answer D Explanation AnswerDExp::Hypotension and bradycardia are the earliest signs of bupivacaine cardiotoxicity.
Answer E AnswerE::Respiratory arrest
Answer E Explanation AnswerEExp::Respiratory arrest is not a complication of bupivacaine injection.
Right Answer RightAnswer::D
Explanation [[Explanation::Bupivacaine is a local anaesthetic used in nerve blocks, epidurals, and intrathecal anesthesia. It acts by binding to neuronal sodium channels and blocking sodium influx. This leads to a block of depolarization. Although bupivacaine is relatively safe with proper handling, when injected accidentally into the bloodstream, it is associated with significant cardiotoxicity. By the same mechanism, it blocks sodium channels in the cardiac muscle fibers often leading to significant bradycardia, hypotension and eventual cardiac arrest. Several reports have shown serious cardiotoxicity with difficult resuscitation especially in pregnant women. Several measures have been introduced to decrease toxicity from anesthetic drugs including better teaching and monitoring of students as well as technical steps such as aspiration, incremental injection, dose control, the use of test doses, and ultrasound guidance.

Educational Objective: Bupivacaine can cause significant cardiotoxicity if injected intravascularly by blocking cardiac sodium channels.
References: Mulroy MF. Systemic toxicity and cardiotoxicity from local anesthetics: incidence and preventive measures. Reg Anesth Pain Med. 2002;27(6):556-61.]]

Approved Approved::Yes
Keyword WBRKeyword::Bupivacaine, WBRKeyword::Cardiotoxicity, WBRKeyword::Local anesthetics, WBRKeyword::Anesthesia
Linked Question Linked::
Order in Linked Questions LinkedOrder::